Belimumab Drives Biomarker Shifts Linked to Renal Response in Lupus Nephritis

Summary: Lupus nephritis is a serious kidney problem caused by the disease lupus. A recent study looked at a medicine called belimumab to see how well it helps heal the kidneys.

Doctors found that they can use certain clues in the blood—called biomarkers—to predict if the medicine will work. They looked at markers like IgA, anti-C1q antibodies, and naive B cells. If patients had high levels of these markers when they started the medicine, and those levels dropped quickly by week 8, they were much more likely to have healthy kidneys two years later.

Also, a quick drop in protein in the urine (by week 12) was a very strong sign that the kidneys were getting better, no matter what medicine the patient took. This research helps doctors know early on if a treatment is working so they can take better care of their patients.

For more details, see rssapp-renalandurologynews-com at renalandurologynews.com/news/lupus-nephritis-belimumab-biomarker-shifts-renal-response/ (opens in new tab)